Fresenius SE Long-Term Investments 2016-2024 | FSNUY
Fresenius SE long-term investments from 2016 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Fresenius SE long-term investments for the quarter ending June 30, 2024 were $4.071B, a INF% increase year-over-year.
- Fresenius SE long-term investments for 2023 were $3.788B, a INF% increase from 2022.
- Fresenius SE long-term investments for 2022 were $0B, a NAN% decline from 2021.
- Fresenius SE long-term investments for 2021 were $0B, a NAN% decline from 2020.
Fresenius SE Annual Long-Term Investments (Millions of US $) |
2023 |
$3,788 |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
Fresenius SE Quarterly Long-Term Investments (Millions of US $) |
2024-06-30 |
$4,071 |
2024-03-31 |
$3,835 |
2023-12-31 |
$3,788 |
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
|
2017-03-31 |
|
2016-12-31 |
|
2016-09-30 |
|
2016-06-30 |
|
2016-03-31 |
|
2015-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$19.347B |
$24.011B |
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|